Pamela J. Stahl

2017

In 2017, Pamela J. Stahl earned a total compensation of $508.7K as Former Chief Commercial Officer at InVivo Therapeutics Holdings, a 70% decrease compared to previous year.

Compensation breakdown

Option Awards$123,574
Salary$335,000
Other$50,076
Total$508,650

Stahl received $335K in salary, accounting for 66% of the total pay in 2017.

Stahl also received $123.6K in option awards and $50.1K in other compensation.

Rankings

In 2017, Pamela J. Stahl's compensation ranked 11,798th out of 14,666 executives tracked by ExecPay. In other words, Stahl earned more than 19.6% of executives.

ClassificationRankingPercentile
All
11,798
out of 14,666
20th
Division
Manufacturing
4,646
out of 5,772
20th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
648
out of 859
25th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
386
out of 531
27th
Industry
Surgical and Medical Instruments and Apparatus
248
out of 336
26th
Source: SEC filing on April 27, 2018.

Stahl's colleagues

We found six more compensation records of executives who worked with Pamela J. Stahl at InVivo Therapeutics Holdings in 2017.

2017

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2017

Richard Toselli

InVivo Therapeutics Holdings

Chief Executive Officer

2017

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2017

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2017

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2017

Melanie Morel-Ferris

InVivo Therapeutics Holdings

Chief Financial Officer

News

You may also like